Updated September 2026Low figures, unlabeled termMetaboost Rx review
An Oklahoma City telehealth brand whose headline GLP-1 figures sit under a new-patient banner, with nothing on the page saying what follows the offer.
The verdict
Metaboost Rx advertises compounded semaglutide from $149 a month and compounded tirzepatide from $199, the second printed beside a struck $299, and the banner above both reads New Patient Offer. A reader planning past the first few months has no published figure to plan with, because nowhere on the public pages does the seller say whether those rates continue after the offer or what they become.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- From
- From $149/mo
- Dose published
- No
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- All 50 states
Metaboost Rx describes itself as a physician-directed telehealth practice for medical weight loss, based in Oklahoma City and serving patients nationwide, and its footer calls it a concierge platform that connects patients with independent providers and state-licensed compounding pharmacies. It runs three GLP-1 programs, semaglutide, tirzepatide and a lower-dose microdose track, plus a newer peptide therapy line for recovery and energy. Its website runs on a platform shared with seven other GLP-1 brands, down to the same compiled code and the same member photographs, and each brand configures its own programs and prices on top of it.
Who writes the prescription, and what do they see?
The platform says plainly that it does not practice medicine or write prescriptions itself, and that every evaluation and prescribing decision belongs to an independent, board-certified U.S. provider who reviews the intake. No provider is named on the homepage, the program pages or the about page, and the only contact listed is a Gmail address, so a patient meets the clinician only after the assessment is under way.
A patient fills in an online assessment of about five to ten minutes covering history, goals and baseline measurements, and a provider reads it and builds a plan. Medication then ships in temperature-controlled, unmarked packaging, with check-ins and secure messaging continuing afterward. The site says nothing is charged if the provider does not approve treatment, and its FAQ answers the commitment question in one word: no long-term commitment is required.
What happens when the dose goes up?
The tirzepatide page sketches the first year as careful dose escalation in month one, a therapeutic dose by month three, and titration handled by the provider at every step, with each dose change listed as included in the flat-rate program. The FAQ adds that a patient switching from another provider may continue at the same or an equivalent dose, while a new patient starts at an introductory one. No milligram schedule is published, so a patient cannot see in advance where the ladder stops.
What the price includes
The homepage pricing block shows semaglutide from $149 a month and tirzepatide from $199 a month, the latter with $299 struck through, and each card lists the online provider visit, the prescription, home delivery and ongoing check-ins as included. The banner over the page calls the $149 a new-patient offer, and the eligibility tool repeats it as plans from $149 confirmed after provider review. What the page never states is the rate after a patient stops being new, which leaves the question a buyer most needs answered, the cost of month four, without an answer anywhere public.
What it claims, and what it cites
The program pages describe the medication as compounded and prepared by partner compounding pharmacies, and the footer states that compounded medications are not FDA-approved and that the FDA has not independently verified their safety, efficacy or quality. No compounding pharmacy is named on any page.
Where it holds up, and where it does not
- Strength: No long-term commitment, per the FAQ
- Strength: No charge if treatment is not approved
- Strength: Provider visit and delivery listed as included
- Strength: Dose changes included in the program
- Limitation: Headline figure labeled a new-patient offer
- Limitation: Rate after the offer is not published
- Limitation: No provider or pharmacy named
- Limitation: No milligram schedule published
What the evidence says about this kind of treatment
The assessment above is about Metaboost Rx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer willing to start at the advertised figure and ask the rate after the offer before the first refill.
- Wrong for
- Someone who needs a published standing monthly rate before committing to any GLP-1 seller.
How Metaboost Rx compares
| Seller | Who it suits | Go |
|---|---|---|
 Cielo | Buyers who want the commitment behind a headline rate spelled out in the asterisk under it | See Cielo → |
 Henry Meds | Patients who want a fixed monthly bill and can read dose as milligrams per shipment | See Henry Meds → |
 FORM | A reader who has priced the manufacturer already and wants a prescriber named | See FORM → |
More GLP-1 telehealth sellers reviews: Citizen MedsClayaClinic SecretClume HealthCLYR HealthCoivas
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $149 a month Metaboost Rx's regular semaglutide price?
- The seller does not say. The homepage banner calls it a new-patient offer, and no page states what a patient pays after that offer ends.
- What does tirzepatide cost?
- The pricing card shows from $199 a month, with $299 struck through beside it, and the same unanswered question about what follows the new-patient offer applies.
- Do I have to commit to a long plan?
- No, according to the FAQ, which says treatment length varies by patient and no long-term commitment is required.
- Is Metaboost Rx legit?
- Metaboost Rx is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Metaboost Rx expensive compared with other GLP-1 telehealth sellers?
- Metaboost Rx publishes a starting figure of $149/mo. Across the 399 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $189, which puts Metaboost Rx below the median, toward the cheaper end. The other 58 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.